Načítá se...
Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial
OBJECTIVE: To assess whether add-back therapy with norethindrone acetate (n. acetate) or n. acetate plus conjugated equine estrogens is superior to maintain bone health in adolescents and young women using gonadotropin-releasing hormone agonists (GnRHa) for endometriosis. GnRHa are associated with d...
Uloženo v:
| Vydáno v: | Obstet Gynecol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4545413/ https://ncbi.nlm.nih.gov/pubmed/26181088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/AOG.0000000000000964 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|